FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101472630> ?p ?o ?g. }

• W2101472630 endingPage "91" @default.
• W2101472630 startingPage "383" @default.
• W2101472630 abstract "Interleukin (IL)-6, a multifunctional regulator of immune response, hematopoiesis, and acute phase reactions, has also been shown to regulate cancer cell proliferation. We have investigated IL-6 signaling pathways and cellular responses in the T47D breast carcinoma cell line. The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration. In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration. IL-6 treatment led to activation of the mitogen-activated protein kinase (MAPK) and the phosphatidylinositol 3'-kinase (PI3K) pathways. Inhibition of MAPK or PI3K activity reversed IL-6- and oncostatin M-stimulated migration. Because cross-talk between cytokine receptors and members of the ErbB family of receptor tyrosine kinases has been described previously, we have examined their interaction in T47D cells. Down-regulation of ErbB receptor activity, through the use of specific pharmacological inhibitors or dominant negative receptor constructs, revealed that IL-6-induced MAPK activation was largely dependent on epidermal growth factor (EGF) receptor activity, but not on ErbB-2 activity. Using a monoclonal antibody that interferes with EGF receptor-ligand interaction, we have shown that in T47D cells, IL-6 cooperates with an EGF receptor autocrine activity loop for signaling through the MAPK and PI3K pathways and for cell migration. Both the tyrosine phosphatase SHP-2 and the multisubstrate docking molecule Gab1, which are potential links between IL-6 and the MAPK/PI3K pathways, were constitutively associated with the active EGF receptor. On IL-6 stimulation, SHP-2 and Gab1 were recruited to the gp130 subunit of the IL-6 receptor and tyrosine phosphorylated, allowing downstream signaling to the MAPK and PI3K pathways. Thus, in T47D breast carcinoma cells, IL-6 acts in synergy with EGF receptor autocrine activity to signal through the MAPK/PI3K pathways. Cooperation between IL-6 and the EGF receptor in T47D breast carcinoma cells illustrates how a combination of multiple stimuli, either exogenous or endogenous, may result in synergistic cellular responses." @default.
• W2101472630 created "2016-06-24" @default.
• W2101472630 creator A5023604575 @default.
• W2101472630 creator A5024560111 @default.
• W2101472630 date "2001-01-01" @default.
• W2101472630 modified "2023-10-17" @default.
• W2101472630 title "Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells." @default.
• W2101472630 cites W1490624051 @default.
• W2101472630 cites W1496109170 @default.
• W2101472630 cites W1500857648 @default.
• W2101472630 cites W1568956696 @default.
• W2101472630 cites W1574013273 @default.
• W2101472630 cites W1579739997 @default.
• W2101472630 cites W1585474702 @default.
• W2101472630 cites W1596047401 @default.
• W2101472630 cites W1601571585 @default.
• W2101472630 cites W1608821961 @default.
• W2101472630 cites W1644491781 @default.
• W2101472630 cites W1779691448 @default.
• W2101472630 cites W1965857260 @default.
• W2101472630 cites W1971209357 @default.
• W2101472630 cites W1976760549 @default.
• W2101472630 cites W1977370355 @default.
• W2101472630 cites W1988917700 @default.
• W2101472630 cites W1995993550 @default.
• W2101472630 cites W1999805805 @default.
• W2101472630 cites W2009837389 @default.
• W2101472630 cites W2014053430 @default.
• W2101472630 cites W2017091728 @default.
• W2101472630 cites W2018570422 @default.
• W2101472630 cites W2021927710 @default.
• W2101472630 cites W2024924098 @default.
• W2101472630 cites W2030624761 @default.
• W2101472630 cites W2033986471 @default.
• W2101472630 cites W2036258710 @default.
• W2101472630 cites W2040142253 @default.
• W2101472630 cites W2042218061 @default.
• W2101472630 cites W2050505054 @default.
• W2101472630 cites W2057393115 @default.
• W2101472630 cites W2064047613 @default.
• W2101472630 cites W2066560193 @default.
• W2101472630 cites W2074356752 @default.
• W2101472630 cites W2078499692 @default.
• W2101472630 cites W2080132950 @default.
• W2101472630 cites W2094111001 @default.
• W2101472630 cites W2111034338 @default.
• W2101472630 cites W2125543544 @default.
• W2101472630 cites W2149456035 @default.
• W2101472630 cites W2168856134 @default.
• W2101472630 cites W2171466517 @default.
• W2101472630 cites W2324496255 @default.
• W2101472630 cites W2427071515 @default.
• W2101472630 cites W2727851827 @default.
• W2101472630 cites W3140542363 @default.
• W2101472630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11196191" @default.
• W2101472630 hasPublicationYear "2001" @default.
• W2101472630 type Work @default.
• W2101472630 sameAs 2101472630 @default.
• W2101472630 citedByCount "78" @default.
• W2101472630 countsByYear W21014726302012 @default.
• W2101472630 countsByYear W21014726302013 @default.
• W2101472630 countsByYear W21014726302014 @default.
• W2101472630 countsByYear W21014726302015 @default.
• W2101472630 countsByYear W21014726302016 @default.
• W2101472630 countsByYear W21014726302017 @default.
• W2101472630 countsByYear W21014726302018 @default.
• W2101472630 countsByYear W21014726302019 @default.
• W2101472630 countsByYear W21014726302020 @default.
• W2101472630 countsByYear W21014726302021 @default.
• W2101472630 countsByYear W21014726302022 @default.
• W2101472630 countsByYear W21014726302023 @default.
• W2101472630 crossrefType "journal-article" @default.
• W2101472630 hasAuthorship W2101472630A5023604575 @default.
• W2101472630 hasAuthorship W2101472630A5024560111 @default.
• W2101472630 hasConcept C101544691 @default.
• W2101472630 hasConcept C11988809 @default.
• W2101472630 hasConcept C128240485 @default.
• W2101472630 hasConcept C170493617 @default.
• W2101472630 hasConcept C185592680 @default.
• W2101472630 hasConcept C203014093 @default.
• W2101472630 hasConcept C2776362946 @default.
• W2101472630 hasConcept C2777553839 @default.
• W2101472630 hasConcept C2777667943 @default.
• W2101472630 hasConcept C2778690821 @default.
• W2101472630 hasConcept C42362537 @default.
• W2101472630 hasConcept C502942594 @default.
• W2101472630 hasConcept C55493867 @default.
• W2101472630 hasConcept C57074206 @default.
• W2101472630 hasConcept C62478195 @default.
• W2101472630 hasConcept C86803240 @default.
• W2101472630 hasConcept C95444343 @default.
• W2101472630 hasConceptScore W2101472630C101544691 @default.
• W2101472630 hasConceptScore W2101472630C11988809 @default.
• W2101472630 hasConceptScore W2101472630C128240485 @default.
• W2101472630 hasConceptScore W2101472630C170493617 @default.
• W2101472630 hasConceptScore W2101472630C185592680 @default.
• W2101472630 hasConceptScore W2101472630C203014093 @default.
• W2101472630 hasConceptScore W2101472630C2776362946 @default.

• next